Amgen Shares Soar by 1,491% Over Last 15 Years

The biotech giant Amgen has delivered impressive returns over the last 15 years. According to data, its market capitalization is now at $241.16 billion. On an annualized basis, Amgen's stock price has grown by 14.92% each year since 2007. This performance puts it ahead of the broader market by a significant margin.

To put this into perspective, if you had invested just $1,000 in Amgen back then, your investment would be worth approximately $8,075 today at its current price of $446.07 per share. This remarkable growth underscores the power of long-term investing and the benefits of compounding returns.

The key takeaway from this example is to recognize how critical it is to hold onto investments over an extended period for their full value to be realized. The data suggests that Amgen has been a consistent performer, but investors must remain vigilant about future market trends and potential risks.